Interpace Diagnostics (IDXG) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
August 9, 2018 4:47 PM EDTRevenue Grew 43% Over the Prior Years Quarter and 14% Over the Prior Period
Record Quarterly Revenue of $5.5 Million
Cash & Cash Equivalents of $10.1 Million with No Long-Term Debt
Now Covered by 27 Regional Blue Cross/Blue Shield Plan for ThyGenX® and ThyraMIR®
Company Successfully Launched New Mutational Panel for Thyroid: ThyGeNEXT
Guidance of Revenues for the Year of Over $20 Million Reaffirmed
Conference Call Thursday August 9, 2018 at 4:30 pm ET
Parsippany, NJ, Aug. 09, 2018 (GLOBE NEWSWIRE) --... More
